Renalytix plc Net Change in Cash
Renalytix plc (RENXF) reported Net Change in Cash of -$3.77 million for the 3-month period ending 2024-09-30, per its 10-Q filed 2024-11-19.
Financial Statements › Cash Flow › Change in Cash
us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect · last filed 2024-11-19
- Renalytix plc cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for the quarter ending 2024-09-30 was -$3.77M.
- Renalytix plc cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for the quarter ending 2023-09-30 was -$10.79M.
- Renalytix plc cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for the quarter ending 2022-09-30 was -$10.29M.
- Renalytix plc cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for the quarter ending 2021-09-30 was -$10.80M.
- Renalytix plc cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for fiscal 2024 was -$20.00M.
- Renalytix plc cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for fiscal 2023 was -$16.65M.
- Renalytix plc cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for fiscal 2022 was -$23.80M.
| Period end | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 3 month | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 6 month | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 9 month | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 12 month |
|---|---|---|---|---|
| 2024-09-30 | -$3.77M 10-Q · filed 2024-11-19 | |||
| 2024-06-30 | -$20.00M 10-K · filed 2024-09-30 | |||
| 2024-03-31 | -$19.98M 10-Q · filed 2024-05-15 | |||
| 2023-12-31 | -$19.06M 10-Q · filed 2024-02-14 | |||
| 2023-09-30 | -$10.79M 10-Q · filed 2024-11-19 | |||
| 2023-06-30 | -$16.65M 10-K · filed 2024-09-30 | |||
| 2023-03-31 | -$8.31M 10-Q · filed 2024-05-15 | |||
| 2022-12-31 | -$17.52M 10-Q · filed 2024-02-14 | |||
| 2022-09-30 | -$10.29M 10-Q · filed 2023-11-14 | |||
| 2022-06-30 | -$23.80M 10-K · filed 2023-09-28 | |||
| 2022-03-31 | -$32.77M 6-K · filed 2023-06-09 | |||
| 2021-12-31 | -$25.20M 6-K · filed 2023-03-30 | |||
| 2021-09-30 | -$10.80M 6-K · filed 2022-11-30 | |||
| 2021-03-31 | $56.78M 6-K · filed 2022-06-30 | |||
| 2020-12-31 | $61.24M 6-K/A · filed 2022-04-29 |